Retour sur lavenir.net
   AGEAS 76.500 € (+0,86 %)     BARCO 7.515 € (+3,94 %)     GBL 74.550 € (+0,95 %)     XIOR 25.225 € (+0,10 %)     ELIA GROUP 120.300 € (-0,33 %)     ARGENX SE 869.000 € (-0,28 %)     SOLVAY 25.420 € (+1,11 %)     COLRUYT 38.700 € (+0,68 %)     KBC 133.350 € (+1,72 %)     SOFINA 248.000 € (+0,65 %)     RECTICEL 12.680 € (+0,79 %)     AB INBEV 68.100 € (+0,74 %)     UCB 210.500 € (+1,15 %)     MELEXIS 68.200 € (+2,71 %)     GIMV 47.350 € (+2,27 %)     BEKAERT 38.200 € (+2,00 %)     VGP 71.400 € (-0,42 %)     BPOST 1.230 € (+2,50 %)     TUBIZE-FIN 178.500 € (+0,79 %)     PROXIMUS 6.365 € (+2,00 %)     MOURY CONSTRUCT 710.000 € (+0,57 %)     TITAN S.A. 49.400 € (+2,28 %)     AZELIS GROUP 12.060 € (+0,42 %)     D'IETEREN GROUP 165.900 € (+1,04 %)     UMICORE 21.760 € (+0,37 %)     KBC ANCORA 95.600 € (+1,70 %)     KINEPOLIS GROUP 50.100 € (+0,80 %)     DEME GROUP 182.000 € (+0,66 %)     MONTEA 64.100 € (+0,94 %)     WDP 20.840 € (+0,87 %)     CMB.TECH 17.400 € (-1,36 %)     RETAIL ESTATES 64.500 € (-0,15 %)     AEDIFICA 65.450 € (-0,23 %)     FAGRON 22.100 € (+0,68 %)     EVS 27.550 € (+0,18 %)     ECONOCOM GROUP 1.455 € (-1,02 %)     SYENSQO 79.150 € (+2,33 %)     TINC 11.040 € (+0,18 %)     DECEUNINCK 2.480 € (0,00 %)     OXURION 0.002 € (0,00 %)     HOME INVEST BE. 17.920 € (+0,45 %)     ACKERMANS V.HAAREN 276.000 € (+1,69 %)     ASCENCIO 52.900 € (+0,76 %)     ONWARD MEDICAL 2.955 € (+2,07 %)     TESSENDERLO 20.600 € (+0,49 %)     VIOHALCO 16.080 € (+4,96 %)     CARE PROPERTY INV. 12.460 € (+0,48 %)     CENERGY 23.180 € (+5,27 %)     AGFA-GEVAERT 0.389 € (+0,78 %)     SHURGARD 23.700 € (+0,21 %)     LOTUS BAKERIES 12 480.000 € (+4,35 %)     ACCENTIS 0.026 € (-1,92 %)     OPTION 4.390 € (+4,03 %)     BREDERODE 105.800 € (+0,19 %)     IBA 15.240 € (0,00 %)     SIPEF 109.200 € (+0,37 %)     BIOTALYS 1.998 € (+0,91 %)     NYXOAH 1.314 € (+0,31 %)     European Medical S 3.520 € (-9,74 %)     NEXTENSA 46.100 € (-0,01 %)  
   AYVENS 9.885 € (-5,59 %)     ODYSSEE TECHNO 18.000 € (0,00 %)     FDJ UNITED 21.920 € (+0,05 %)     ASML HOLDING 1 485.400 € (+2,72 %)     STMICROELECTRONICS 44.770 € (+3,03 %)     AXA 44.660 € (-0,16 %)     ASM INTERNATIONAL 831.600 € (+2,19 %)     CTP 13.320 € (-0,30 %)     SHELL PLC 41.275 € (-0,10 %)     ENGIE 23.580 € (-1,87 %)     HEINEKEN 70.780 € (+0,06 %)     TOTALENERGIES 79.250 € (-0,09 %)     AIR LIQUIDE 164.820 € (+1,02 %)     VIRIDIEN 92.550 € (+0,16 %)     KERING 228.400 € (-1,97 %)     ACCSYS 0.750 € (-9,09 %)     SOLOCAL GROUP 4.135 € (-0,36 %)     UMG 14.700 € (-0,34 %)     EXOSENS 60.400 € (-0,41 %)     GENFIT 10.940 € (-5,36 %)     COFACE 17.000 € (-2,80 %)     RENAULT 27.380 € (-0,11 %)     EUROFINS SCIENT. 77.300 € (+1,13 %)     CAPITAL B 6.082 € (+6,89 %)     AIRBUS 194.220 € (+0,43 %)     ROBERTET 754.000 € (+3,71 %)     GALP ENERGIA-NOM 21.820 € (-0,32 %)     UNIBAIL-RODAMCO-WE 93.380 € (+0,28 %)     ING GROEP N.V. 32.220 € (+1,59 %)     SOCIETE GENERALE 74.780 € (+3,02 %)     ACCOR 46.080 € (+1,10 %)     FIGEAC AERO 10.840 € (+4,23 %)     PHARMING GROUP 0.914 € (-0,33 %)     SBM OFFSHORE 36.580 € (-0,05 %)     TELEPERFORMANCE 69.620 € (-0,14 %)     CRCAM LANGUED CCI 87.000 € (+1,16 %)     PHILIPS KON 21.620 € (+0,09 %)     EDP 4.779 € (-0,58 %)     SCHNEIDER ELECTRIC 295.650 € (+3,46 %)     LVMH 407.150 € (+1,08 %)     HEINEKEN HOLDING 66.300 € (+0,61 %)     CBI 0.154 € (+14,26 %)     PUBLICIS GROUPE SA 98.140 € (+0,64 %)     VALNEVA 2.832 € (+1,14 %)     PERNOD RICARD 59.460 € (+0,03 %)     UBISOFT ENTERTAIN 5.338 € (+0,57 %)     SENSORION 9.085 € (-1,11 %)     EXOR NV 70.300 € (+2,63 %)     EDENRED 28.120 € (-0,92 %)     PROSUS 36.200 € (+0,98 %)     BNP PARIBAS ACT.A 101.840 € (+1,09 %)     B.COM.PORTUGUES 1.190 € (+1,15 %)     TME PHARMA 0.111 € (-2,63 %)     BIOPHYTIS 0.049 € (-2,96 %)     MAUREL ET PROM 8.215 € (-0,67 %)     PLUXEE 14.740 € (-1,21 %)     NOS, SGPS 5.470 € (-0,73 %)     ETHERO 0.710 € (+14,70 %)     FASTNED 43.300 € (+4,59 %)     CORTICEIRA AMORIM 6.990 € (0,00 %)  
News Réglementées
28/08/2026 15:05

IGEL Expands Endpoint Options for Healthcare and Industrial Environments with Teguar Hardware

EQS-News: IGEL / Key word(s): Agreement/Contract
IGEL Expands Endpoint Options for Healthcare and Industrial Environments with Teguar Hardware

28.08.2026 / 15:05 CET/CEST
The issuer is solely responsible for the content of this announcement.


Teguar's purpose-built medical and industrial systems add compatible hardware options for IGEL deployments in specialized endpoint environments

FORT LAUDERDALE, Fla., Aug. 28, 2026 /PRNewswire/ -- IGEL®, a global software company delivering the IGEL Adaptive Secure Endpoint Platform™, today announced that Teguar has joined the IGEL Ready ecosystem, with selected hardware validated for use with IGEL OS. The partnership gives customers additional hardware options for endpoint deployments in healthcare, manufacturing, warehouses, and other specialized operational environments.

IGEL Expands Endpoint Options for Healthcare and Industrial Environments with Teguar Hardware

Teguar develops purpose-built computing systems for settings where conventional commercial devices may not meet environmental, durability, or workflow requirements. Its portfolio includes rugged and waterproof industrial computers, as well as all-in-one computers and tablets designed for healthcare environments.

IGEL complements this hardware with IGEL OS, an immutable operating system for secure endpoint access, and the IGEL Universal Management Suite™ (UMS™), which enables centralized policy, configuration, software delivery, updates, and fleet management across distributed endpoint environments.

"Organizations are extending secure access into environments where endpoint reliability, physical durability, and centralized governance all matter," said Jim Airdo, Senior VP of Strategic Alliances at IGEL. "By welcoming Teguar into the IGEL Ready ecosystem, we are giving customers more validated hardware choices while helping them establish a trusted and consistently managed endpoint layer."

The combined offering is designed for organizations that need to balance three requirements: hardware suited to specialized operating environments, a secure endpoint foundation, and centralized management across distributed devices.

In manufacturing and industrial environments, Teguar hardware can support use cases where devices must operate reliably under conditions that differ from a traditional office. In healthcare, Teguar systems can support shared workspaces, clinical access, and other workflows that require purpose-built endpoint hardware.

IGEL OS provides an immutable operating foundation that helps reduce endpoint attack surface by design. UMS™ gives IT teams centralized control over endpoint configuration and software delivery, helping them maintain consistency across devices deployed in multiple facilities and operational settings.

"Organizations continue to modernize their endpoint strategy, and the combination of IGEL's immutable operating system with Teguar's purpose-built hardware creates a powerful solution for demanding environments," said Kevin Jones, Teguar Global VP of Sales and Marketing. "Through the IGEL Ready program, Teguar and IGEL have ensured compatibility between key Teguar medical and industrial products and IGEL OS, enabling customers to deploy centrally managed, secure endpoints with confidence."

IGEL supports Zero Trust-aligned architectures by strengthening the device layer on which access decisions depend. When deployed on validated Teguar hardware, IGEL OS can provide a consistent and centrally governed endpoint foundation for access to virtual applications, cloud desktops, SaaS applications, browser-based workflows, and operational systems.

The IGEL Ready program helps customers identify technologies and endpoint hardware validated for use with IGEL solutions. Teguar's participation expands the range of purpose-built hardware available to organizations deploying IGEL in healthcare, manufacturing, industrial, and other specialized environments.

To learn more about this partnership, visit:

About IGEL

IGEL® is a global software company delivering the IGEL Adaptive Secure Endpoint Platform™, a trusted and governed endpoint platform for secure access to cloud, VDI, DaaS, SaaS, Secure Browsers, enterprise applications, as well as OT endpoints. At its foundation is IGEL OS, an immutable operating system that helps reduce endpoint attack surface, preserve a known-good endpoint state, and support secure access across distributed work environments. Through the IGEL Preventative Security Model®, the platform adds attested workload delivery, centralized governance, and contextual enforcement, aligning endpoint security with Zero Trust and SSE/SASE architectures from key IGEL Ready partners.

IGEL Business Continuity & Disaster Recovery™ (BC&DR) helps organizations restore secure access on Windows endpoints affected by ransomware, other cyberattacks, or outages. Founded in 2001, IGEL is headquartered in Germany with U.S. offices in San Francisco and Fort Lauderdale, working with an ecosystem of 130 leading technology brands. Learn more at www.igel.com.

Windows is a trademark of the Microsoft group of companies.

IGEL logo

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/igel-expands-endpoint-options-for-healthcare-and-industrial-environments-with-teguar-hardware-302862373.html

rt.gif?NewsItemId=EN35785&Transmission_Id=202608280900PR_NEWS_EURO_ND__EN35785&DateId=20260828


28.08.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2390494  28.08.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière